Cavu Management, LP's Form 4 filing
Lantern Pharma Inc. (LTRN) · filed May 28, 2024
- Accession no.
- 0001104659-24-065619
- Filed
- May 28, 2024, 4:31 PM ET
- Trade date
- May 23-24, 2024
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market sales total $189.1K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cavu Management, LPCIK 0001813270 | 10% Owner |
| Cavu Advisors, LLCCIK 0001813310 | 10% Owner |
| BP Directors, LPCIK 0001813311 | 10% Owner |
| Kreis Leslie W.CIK 0001813316 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 23, 2024 | Common Stock | SSaleDisposed | −930 | $6.25 | −$5,812.5 | 59,326 | Indirect | Duplicate filing |
| May 24, 2024 | Common Stock | SSaleDisposed | −1,859 | $6.33 | −$11,767.47 | 57,467 | Indirect | Duplicate filing |
| May 23, 2024 | Common Stock | SSaleDisposed | −6,944 | $6.25 | −$43,400 | 443,174 | Indirect | Duplicate filing |
| May 24, 2024 | Common Stock | SSaleDisposed | −13,888 | $6.33 | −$87,911.04 | 429,286 | Indirect | Duplicate filing |
| May 23, 2024 | Common Stock | SSaleDisposed | −2,126 | $6.25 | −$13,287.5 | 135,706 | Indirect | Duplicate filing |
| May 24, 2024 | Common Stock | SSaleDisposed | −4,253 | $6.33 | −$26,921.49 | 131,453 | Indirect | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.